Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry (v3.7.0) is added to the record history, and the prior v3.6.6 entry is removed. This reflects a minor system/version update to the page rather than changes to trial data.SummaryDifference0.1%

- Check76 days agoChange DetectedThe footer shows a new revision label as part of a minor maintenance update, replacing the previous version. This change does not affect the study content or user interactions.SummaryDifference0.1%

- Check90 days agoChange DetectedA new study-record version (13) was added, with the record returned for quality control on 2026-08-14 and QC not concluded; multiple sections of the record were updated, including Study Status, Study Description, Arms/Interventions, Eligibility, Outcomes, and Contacts/Locations.SummaryDifference2%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.